Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 919 questions Show Answers
To ask the Scottish Government how many numbered training places have been available for trainee consultants specialising in rheumatoid arthritis in each of the last five years.
To ask the Scottish Government whether it will host a summit on rheumatoid arthritis involving key stakeholders in the NHS and local authorities to highlight the importance that it gives to tackling this condition.
To ask the Scottish Government what (a) recent assessment it has made of the effectiveness of rheumatoid arthritis services and (b) steps it (i) is taking and (ii) plans to take to encourage NHS boards to deliver services in line with this assessment in the next six months.
To ask the Scottish Government what assessment it has made of (a) regional variations in the availability of treatment for rheumatoid arthritis approved by the National Institute for Health and Clinical Excellence (NICE) and (b) the implementation of NICE clinical guideline 79 in each NHS board area.
To ask the Scottish Government what steps it is taking to ensure that GPs have the appropriate skills and knowledge to develop the ability of people diagnosed with rheumatoid arthritis to self-care and manage pain.
To ask the Scottish Government what assessment it has made of the effect of changes in food prices on families.
To ask the Scottish Government what plans it has to encourage the sharing of good practice among health professionals in treating rheumatoid arthritis.
To ask the Scottish Government what proportion of patients with rheumatoid arthritis is expected in the next two years to receive a second anti-tumour necrosis factor (anti-TNF) treatment used sequentially after the failure of a first anti-TNF treatment; how many patients with rheumatoid arthritis will not be provided with sequential treatments with anti-TNF drugs over the next five years as a result of rulings made by the Scottish Medicines Consortium or the National Institute for Health and Clinical Excellence (NICE); what records it holds for benchmarking purposes on the use of anti-TNF treatments in other EU countries, and what assessment it has made of how patterns of use of anti-TNF treatments in Scotland differ from that in (a) the rest of the UK and (b) other EU countries.
To ask the Scottish Government what plans it has to conduct a formal evaluation of NHS self-management programmes for patients with rheumatoid arthritis.
To ask the Scottish Government how many adults in (a) the Cowdenbeath constituency, (b) NHS Fife area, (c) Scotland and (d) the UK have died from rheumatoid arthritis in each year since 2007.